George K. Ng serves as Executive at Sorrento Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, George K. Ng has executed 11 insider transactions totaling $1.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 30, 2024 involved purchasing 10,000 shares valued at $27.0K.
George K. Ng currently holds 20,000 shares of Sorrento Therapeutics, Inc. (SRNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George K. Ng has been a net buyer of SRNE stock. They have purchased $1.1M and sold $0 worth of shares.
George K. Ng's most recent insider trade was on Jan 30, 2024, when they purchased 10,000 shares at $2.70 per share.
Get notified when new Form 4 filings are submitted
| $0.25 |
| Discretionary |
| Oct 10, 2023 | PCSA | $25.0K | Award | 100,000 | $0.25 | Discretionary |
| Feb 28, 2018 | SRNE | $0 | Other | 163,469 | $N/A | Discretionary |
| Feb 28, 2018 | SRNE | $895.5K | Purchase | 90,000 | $9.95 | Discretionary |
| Sep 11, 2017 | SRNE | $0 | Other | 89,339 | $N/A | Discretionary |
| Nov 8, 2016 | SRNE | $0 | Award | 89,338 | $N/A | Discretionary |
| Aug 21, 2015 | SRNE | $6.7K | Purchase | 500 | $13.49 | Discretionary |
| Aug 21, 2015 | SRNE | $734 | Purchase | 55 | $13.34 | Discretionary |
| Aug 21, 2015 | SRNE | $4.5K | Purchase | 333 | $13.55 | Discretionary |
| Aug 3, 2015 | SRNE | $131.7K | Purchase | 11,453 | $11.50 | Discretionary |